Page 80 - RaRió 9
P. 80
mayo-agosto - 2020 / 3(9)
I 80 I
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Gu, X. et al. (2020). Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-
506. doi: 10.1016/S0140-6736(20)30183-5
Jensen, S., & Thomsen, A. R. (2012). Sensing of RNA viruses: a review of innate immune receptors
involved in recognizing RNA virus invasion. Journal of Virology, 86(6), 2900-2910. doi:
10.1128/JVI.05738-11
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007).
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and
nucleocapsid proteins function as interferon antagonists. Journal of Virology, 81(2), 548-
557. doi: 10.1128/JVI.01782-06
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., Zhang, Q. & Wu,
J. (2020). Coronavirus infections and immune responses. Journal of Medical Virology,
92(4), 424-432. https://doi.org/10.1002/jmv.25685
Li, S.-W., Wang, C.-Y., Jou, Y.-J., Huang, S.-H., Hsiao, L.-H., Wan, L.,Lin, Y.-J., Kung, S.-H. & Lin, C.-
W. (2016). SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway
through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6. International
Journal of Molecular Sciences, 17(5), 678. doi: 10.3390/ijms17050678
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular immune pathogenesis and diag-
nosis of COVID-19. Journal of Pharmaceutical Analysis, 10(2), 102-108. doi: 10.1016/j.
jpha.2020.03.001
Lui, P.-Y., Wong, L.-Y. R., Fung, C.-L., Siu, K.-L., Yeung, M.-L., Yuen, K.-S., Chan, Ch.-P., Woo, P.
Ch., Yuen, K.-y. & Jin, D.-Y. (2016). Middle East respiratory syndrome coronavirus M
protein suppresses type I interferon expression through the inhibition of TBK1-depen-
dent phosphorylation of IRF3. Emerging Microbes & Infections, 5(1), 1-9. doi: 10.1038 /
emi.2016.33
Marshall, J. S., Warrington, R., Watson, W., & Kim, H. L. (2018). An introduction to immunology
and immunopathology. Allergy, Asthma & Clinical Immunology, 14(2), 1-10. doi: 10.1186
/ s13223-018-0278-1
Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G., Suliman, T ., Barchet, W., Weber,
F., Drosten, Ch., & Müller, M. A. (2013). Middle East respiratory syndrome coronavirus
La respuesta inmunitaria
frente al virus SARS-CoV-2
Aguilar & Sánchez